Healthy Skepticism Library item: 6862
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Larkin M.
Whose article is it anyway?
Lancet 1999 Jul 10; 354:(9173):136
Abstract:
Wyeth-Ayerst Laboratories, maker of the weight-loss drug dexfenfluramine, had paid ghost-writers for articles promotion obesity treatments and then used prominent researchers to publish the work in journals under their names.
Keywords:
*news story/United States/Wyeth/obesity/ghost-writing/ payment for writing articles/PROMOTION DISGUISED: GHOST-WRITING AND JOURNAL ARTICLES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS
Authorship*
Biomedical Research*
Disclosure
Drug Industry*
Editorial Policies*
Information Dissemination
Peer Review, Research
Periodicals
Publishing/standards*
